Unknown

Dataset Information

0

Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.


ABSTRACT: X-linked severe combined immunodeficiency (X-SCID) has been successfully treated by hematopoietic stem cell (HSC) transduction with retroviral vectors expressing the interleukin-2 receptor subunit gamma gene (IL2RG), but several patients developed malignancies due to vector integration near cellular oncogenes. This adverse side effect could in principle be avoided by accurate IL2RG gene editing with a vector that does not contain a functional promoter or IL2RG gene. Here, we show that adeno-associated virus (AAV) gene editing vectors can insert a partial Il2rg cDNA at the endogenous Il2rg locus in X-SCID murine bone marrow cells and that these ex vivo-edited cells repopulate transplant recipients and produce CD4+ and CD8+ T cells. Circulating, edited lymphocytes increased over time and appeared in secondary transplant recipients, demonstrating successful editing in long-term repopulating cells. Random vector integration events were nearly undetectable, and malignant transformation of the transplanted cells was not observed. Similar editing frequencies were observed in human hematopoietic cells. Our results demonstrate that therapeutically relevant HSC gene editing can be achieved by AAV vectors in the absence of site-specific nucleases and suggest that this may be a safe and effective therapy for hematopoietic diseases where in vivo selection can increase edited cell numbers.

SUBMITTER: Hiramoto T 

PROVIDER: S-EPMC5993949 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.

Hiramoto Takafumi T   Li Li B LB   Funk Sarah E SE   Hirata Roli K RK   Russell David W DW  

Molecular therapy : the journal of the American Society of Gene Therapy 20180306 5


X-linked severe combined immunodeficiency (X-SCID) has been successfully treated by hematopoietic stem cell (HSC) transduction with retroviral vectors expressing the interleukin-2 receptor subunit gamma gene (IL2RG), but several patients developed malignancies due to vector integration near cellular oncogenes. This adverse side effect could in principle be avoided by accurate IL2RG gene editing with a vector that does not contain a functional promoter or IL2RG gene. Here, we show that adeno-asso  ...[more]

Similar Datasets

| S-EPMC5552779 | biostudies-literature
| S-EPMC3808136 | biostudies-other
| S-EPMC6321811 | biostudies-literature
| PRJNA483309 | ENA
| PRJNA913807 | ENA
| PRJNA310351 | ENA
| PRJNA754789 | ENA
| PRJNA360636 | ENA
| S-EPMC6340893 | biostudies-other
| S-EPMC4031469 | biostudies-literature